Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter F Orio

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Practical Radiation Oncology|October 24, 2024
Prospective Evaluation of Supplemental External Beam Radiation Therapy With Palladium-103 Prostate Brachytherapy: Long-Term Results of the 44/20/0 TrialsMartin T King, Gregory S Merrick, Robert W Galbreath, et al.
Cancer|March 1, 2024
Secondary analysis of late major gastrointestinal and genitourinary toxicities in unfavorable-risk prostate cancer patients receiving docetaxel: Insights from a randomized trialTyler Walburn, Ming-Hui Chen, Marian Loffredo, et al.
Radiation Oncology (London, England)|July 24, 2009
cExternal beam radiation results in minimal changes in post void residual urine volumes during the treatment of clinically localized prostate cancerPeter F Orio, Gregory S Merrick, Zachariah A Allen, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2006
15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experienceJohn E Sylvester, Peter D Grimm, John C Blasko, et al.
JCO Oncology Practice|September 16, 2021
Disproportionate Negative Impact of the Radiation Oncology Alternative Payment Model on Rural Providers: A Cost Identification Analysis of Medicare ClaimsConstantine A Mantz, Nikhil G Thaker, Praveen Pendyala, et al.
American Journal of Clinical Oncology|December 9, 2008
Effects of the time interval between prostate brachytherapy and postimplant dosimetric evaluation in community practice: analysis of the Pro-Qura databasePeter F Orio, Gregory S Merrick, Peter Grimm, et al.
Journal of Contemporary Brachytherapy|March 18, 2016
Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancerVinayak Muralidhar, Michael Xiang, Peter F Orio, et al.
Brachytherapy|November 1, 2020
Utilization of multimodality therapy with primary radical prostatectomy versus radiation therapy for Gleason 8-10 prostate cancerMartin T King, Vinayak Muralidhar, David D Yang, et al.
Journal of the American Medical Informatics Association : JAMIA|March 25, 2017
Implementing patient-reported outcome surveys as part of routine care: lessons from an academic radiation oncology departmentLisa S Rotenstein, Ankit Agarwal, Kelly O'Neil, et al.
Cancer|December 5, 2024
Biochemical response to neoadjuvant androgen deprivation therapy before radiation therapy and the risk of death in patients with unfavorable-risk prostate cancer: A secondary analysis of a randomized clinical trialMutlay Sayan, Ming-Hui Chen, Jing Wu, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Practical Radiation Oncology|October 24, 2024
Prospective Evaluation of Supplemental External Beam Radiation Therapy With Palladium-103 Prostate Brachytherapy: Long-Term Results of the 44/20/0 TrialsMartin T King, Gregory S Merrick, Robert W Galbreath, et al.
Cancer|March 1, 2024
Secondary analysis of late major gastrointestinal and genitourinary toxicities in unfavorable-risk prostate cancer patients receiving docetaxel: Insights from a randomized trialTyler Walburn, Ming-Hui Chen, Marian Loffredo, et al.
Radiation Oncology (London, England)|July 24, 2009
cExternal beam radiation results in minimal changes in post void residual urine volumes during the treatment of clinically localized prostate cancerPeter F Orio, Gregory S Merrick, Zachariah A Allen, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2006
15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experienceJohn E Sylvester, Peter D Grimm, John C Blasko, et al.
JCO Oncology Practice|September 16, 2021
Disproportionate Negative Impact of the Radiation Oncology Alternative Payment Model on Rural Providers: A Cost Identification Analysis of Medicare ClaimsConstantine A Mantz, Nikhil G Thaker, Praveen Pendyala, et al.
American Journal of Clinical Oncology|December 9, 2008
Effects of the time interval between prostate brachytherapy and postimplant dosimetric evaluation in community practice: analysis of the Pro-Qura databasePeter F Orio, Gregory S Merrick, Peter Grimm, et al.
Journal of Contemporary Brachytherapy|March 18, 2016
Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancerVinayak Muralidhar, Michael Xiang, Peter F Orio, et al.
Brachytherapy|November 1, 2020
Utilization of multimodality therapy with primary radical prostatectomy versus radiation therapy for Gleason 8-10 prostate cancerMartin T King, Vinayak Muralidhar, David D Yang, et al.
Journal of the American Medical Informatics Association : JAMIA|March 25, 2017
Implementing patient-reported outcome surveys as part of routine care: lessons from an academic radiation oncology departmentLisa S Rotenstein, Ankit Agarwal, Kelly O'Neil, et al.
Cancer|December 5, 2024
Biochemical response to neoadjuvant androgen deprivation therapy before radiation therapy and the risk of death in patients with unfavorable-risk prostate cancer: A secondary analysis of a randomized clinical trialMutlay Sayan, Ming-Hui Chen, Jing Wu, et al.
Pageof 9